Abiopharma

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

ABOU RESIDENC-M (ABOU-M) was added to the list of traded instruments on TASE exchange

Salarius Pharmaceuticals Inc. (SLRX) was removed from the list of traded instruments on NASDAQ exchange

FibroGen Inc (FGEN) was removed from the list of traded instruments on NASDAQ exchange

Cidara Therapeutics Inc. (CDTX) was removed from the list of traded instruments on NASDAQ exchange

NASDAQ symbol attribute type Security_Name was changed. Previous value: FibroGen, Inc - Common Stock. New value: FibroGen, Inc - Common Stock.

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: FibroGen, Inc - Common Stock.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: FibroGen, Inc - Common Stock.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Salarius Pharmaceuticals, Inc. - Common Stock.

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Salarius Pharmaceuticals, Inc. - Common Stock.